Actively Recruiting
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
Led by Northwestern University · Updated on 2025-08-11
575
Participants Needed
1
Research Sites
251 weeks
Total Duration
On this page
Sponsors
N
Northwestern University
Lead Sponsor
T
The California Medical Innovations Institute, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Swallowing difficulties are extremely common and result in substantial morbidity, reduction in the quality of life, and mortality related to malnutrition and complications from regurgitation and aspiration. Unfortunately, our understanding regarding the pathophysiology of dysphagia and GERD has been hampered by focusing predominantly on circular muscle activity and ignoring the essential biomechanical properties of the esophageal wall that promote normal emptying. Our initial work explored the relationship between intrabolus pressure (IBP) and esophagogastric junction (EGJ) compliance as a metric for outflow resistance. This work highlighted the direct relationship between IBP and EGJ opening and was the foundation for the development of the classification scheme utilized around the world to diagnose esophageal motor disorders: "the Chicago Classification" (CC). Despite this improved understanding focused on bolus transit dynamics, there are still significant gaps in our scientific understanding centered on the lack of a true correlate for symptoms, reliable predictive models and effective treatments for Functional dysphagia, IEM and EGJOO. Given these limitations, we have developed novel approaches that combine assessments of primary and secondary peristalsis (a NeuroMyogenic Model of esophageal function). These will leverage our recent findings supporting the importance of the esophageal response to distension in bolus clearance, noting that this response of the esophageal wall to bolus retention or reflux is one of the most essential functions of the esophagus in preventing complications of aspiration, or reflux injury. We will also include an assessment of esophageal geometry and wall biomechanics (elasticity/dilatation) as these carry essential interactions with esophageal function that are overlooked in the current diagnostic paradigms. In order to test our hypothesis that wall mechanics are a major determinant of esophageal diseases, we had to develop new approaches and new technology to directly measure mechanical wall state, descending inhibition and LES opening. Using impedance techniques combined with manometry, we are now capable of assessing IBP and diameter changes across a space-time continuum (4D HRM). We also developed physics-based hybrid diagnostics that include a FLIP technique to assess esophageal work and power during volumetric distention (FLIP-MECH) and a fluoroscopy approach that simultaneously assesses esophageal diameter-pressure relationships (Fluoro-MECH). We also developed a new approach, Interactive FLIP Panometry, which facilitates an assessment of descending inhibition and the mechanism behind impaired LES opening. These tools will allow us to expand our models to combine an assessment of neuromyogenic function simultaneously with geometry. Our overarching goal will be to study well-defined patient populations (Functional Dysphagia, IEM/GERD, EGJOO and Achalasia) before and after targeted interventions to test the NeuroMyogenic and MechanoGeometric Model. This work will build upon the previous success of the CC and help advance the evolution of the CC by defining new, relevant biomechanical physiomarkers of disease activity that can identify new targets for therapeutic intervention and facilitate prediction of clinical outcomes.
CONDITIONS
Official Title
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects aged 18 to 85 years inclusive
- Females of childbearing potential must use highly effective contraceptive methods
- Mentally capable of providing informed consent
- Presenting with dysphagia, regurgitation, chest pain, food impaction, or referral for treatment of achalasia, GERD, scleroderma, or endoscopy negative dysphagia
- Able to undergo endoscopy with FLIP, 4D High Resolution Manometry, and 24-hour pH impedance probe
You will not qualify if you...
- Currently participating in another clinical trial or completed one within the past 8 weeks
- Active severe esophagitis (Grade C or above); may be eligible once healed if dysphagia persists
- Evidence of mechanical obstruction due to stricture or previous bowel obstruction
- Long-segment Barrett's metaplasia
- Unstable medical illness under ongoing evaluation and treatment, except stable hypertension, diabetes, or ischemic heart disease
- Current drug or alcohol abuse or dependency
- Neurologic or cognitive impairment unsuitable for research participation
- Severe mental illness such as uncontrolled major depression with suicidal ideation, active psychosis, or schizophrenia-spectrum disorder
- Pregnancy
- Bleeding disorders or need for anticoagulation that cannot be stopped for endoscopy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
Research Team
J
John E Pandolfino, MD
CONTACT
D
Dustin A Carlson, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here